Koning CC[Author] - Search Results

Year	Number of Results
1996	3
1997	1
1998	1
2000	1
2005	5
2007	3
2008	5
2009	5
2010	13
2011	16
2012	20
2013	11
2014	3
2015	3
2016	2
2017	1
2018	1
2021	1
2022	1

1

[Bladder-conserving treatment for bladder cancer: potential of and developments in radiotherapy].

Hulshof MC, Pieters BR, Koning CC. Hulshof MC, et al. Among authors: koning cc. Ned Tijdschr Geneeskd. 2013;157(19):A5556. Ned Tijdschr Geneeskd. 2013. PMID: 23657098 Review. Dutch.

2

Immune Monitoring during Therapy Reveals Activitory and Regulatory Immune Responses in High-Risk Neuroblastoma.

Szanto CL, Cornel AM, Tamminga SM, Delemarre EM, de Koning CCH, van den Beemt DAMH, Dunnebach E, Tas ML, Dierselhuis MP, Tytgat LGAM, van Noesel MM, Kraal KCJM, Boelens JJ, Huitema ADR, Nierkens S. Szanto CL, et al. Among authors: de koning cch. Cancers (Basel). 2021 Apr 26;13(9):2096. doi: 10.3390/cancers13092096. Cancers (Basel). 2021. PMID: 33926057 Free PMC article.

3

Reirradiation and hyperthermia for radiation-associated sarcoma.

de Jong MA, Oldenborg S, Bing Oei S, Griesdoorn V, Kolff MW, Koning CC, van Tienhoven G. de Jong MA, et al. Among authors: koning cc. Cancer. 2012 Jan 1;118(1):180-7. doi: 10.1002/cncr.26252. Epub 2011 Jun 28. Cancer. 2012. PMID: 21713762 Free article.

4

[Guideline on 'non-small cell lung carcinoma; staging and treatment'].

van Meerbeeck JP, Koning CC, Tjan-Heijnen VC, Boekema AG, Kaandorp CJ, Burgers JS. van Meerbeeck JP, et al. Among authors: koning cc. Ned Tijdschr Geneeskd. 2005 Jan 8;149(2):72-7. Ned Tijdschr Geneeskd. 2005. PMID: 15688837 Review. Dutch.

5

Prevalence and risk factors of radiation-induced growth hormone deficiency in childhood cancer survivors: a systematic review.

Mulder RL, Kremer LC, van Santen HM, Ket JL, van Trotsenburg AS, Koning CC, Schouten-van Meeteren AY, Caron HN, Neggers SJ, van Dalen EC. Mulder RL, et al. Among authors: koning cc. Cancer Treat Rev. 2009 Nov;35(7):616-32. doi: 10.1016/j.ctrv.2009.06.004. Epub 2009 Jul 28. Cancer Treat Rev. 2009. PMID: 19640651 Review.

6

Toxicity of concurrent radiochemotherapy for locally advanced non--small-cell lung cancer: a systematic review of the literature.

Koning CC, Wouterse SJ, Daams JG, Uitterhoeve LL, van den Heuvel MM, Belderbos JS. Koning CC, et al. Clin Lung Cancer. 2013 Sep;14(5):481-7. doi: 10.1016/j.cllc.2013.03.002. Epub 2013 Jun 7. Clin Lung Cancer. 2013. PMID: 23751283 Free article. Review.

7

Clinical Implications of Co-Inhibitory Molecule Expression in the Tumor Microenvironment for DC Vaccination: A Game of Stop and Go.

Vasaturo A, Di Blasio S, Peeters DG, de Koning CC, de Vries JM, Figdor CG, Hato SV. Vasaturo A, et al. Among authors: de koning cc. Front Immunol. 2013 Dec 3;4:417. doi: 10.3389/fimmu.2013.00417. Front Immunol. 2013. PMID: 24348481 Free PMC article. Review.

8

[Guideline 'Melanoma' (3rd revision)].

van Everdingen JJ, van der Rhee HJ, Koning CC, Nieweg OE, Kruit WH, Coebergh JW, Ruiter DJ; Nederlandse Melanoom Werkgroep. van Everdingen JJ, et al. Among authors: koning cc. Ned Tijdschr Geneeskd. 2005 Aug 13;149(33):1839-43. Ned Tijdschr Geneeskd. 2005. PMID: 16128181 Dutch.

9

Comparison of three radiotherapy modalities on biochemical control and overall survival for the treatment of prostate cancer: a systematic review.

Pieters BR, de Back DZ, Koning CC, Zwinderman AH. Pieters BR, et al. Among authors: koning cc. Radiother Oncol. 2009 Nov;93(2):168-73. doi: 10.1016/j.radonc.2009.08.033. Epub 2009 Sep 11. Radiother Oncol. 2009. PMID: 19748692 Review.

10

[Re-irradiation of painful bone metastases].

Koning CC, Nortier JW. Koning CC, et al. Ned Tijdschr Geneeskd. 2012;156(41):A5296. Ned Tijdschr Geneeskd. 2012. PMID: 23062263 Dutch.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results